Development of scalable processes to prepare a key chiral, nonracemic intermediate en route to LpxC inhibitors for Gram-negative infections von Sferdean, Calin D., Jaherun, Tuba, Sobieray, Denis M., Vairagoundar, Rajendran, VanderRoest, Ronald J., Westrick, Valerie S., Ghosh, Samir, Mills, Kent A., Millheim, Dominic, Koch, Jason D., Hester, Darryl, Falahatpisheh, Kamran, Walker, Daniel P.

Volltext